Foot and Ankle Device Market Research Report Information by Device Type (Orthopedic Implants and Devices (Fixation Devices (Internal Fixation Devices (Screws, Plates, Wires & Pins, Fusion Nails, Staple ), External Fixation Devices (Unilateral Fixators , Ring Ankle Fixators, Hybrid Fixators)), Joint Implants (Ankle Implants (Ankle Replacement Devices), Subtalar Joint Implants/Subtalar Joint Reconstruction Devices , Phalangeal Implants)), Soft-Tissue Management Devices (Artificial Tendons & Ligaments, Musculoskeletal Reinforcement Devices), P

Global Foot and Ankle Device Market Overview

The Foot and Ankle Device Market was valued at USD 5.88 Billion in 2024. The Foot and Ankle Device Market industry is projected to grow from USD 6.25 Billion in 2025 to USD 12.68 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.32% during the forecast period (2025-2035).

The increasing incidence of sports-related injuries, rising awareness and patient education and research and innovation are driving the growth of the Foot and Ankle Device Market.

As per the Analyst at MRFR, the increasing incidence of sports-related injuries, rising awareness and patient education, and research and innovation are major factors driving the growth of the Foot and Ankle Device Market. 

However, stringent regulatory requirements, reimbursement challenges, and voluntary product recalls by market players are expected to hamper market expansion. Nevertheless, the growing geriatric population and technological advancements in device design are anticipated to create lucrative opportunities for industry.

 FIGURE 1: FOOT AND ANKLE DEVICE MARKET VALUE (2019-2035) USD BILLION

 Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Foot and Ankle Device Market Opportunity

GROWING GERIATRIC POPULATION

The rapidly expanding geriatric population worldwide is creating highly lucrative growth opportunities for the Foot and Ankle Device Market, driven by the increasing prevalence of age-related orthopedic conditions such as osteoarthritis, rheumatoid arthritis, fractures, and degenerative bone disorders. As individuals age, the natural wear and tear on joints, reduced bone density, and slower healing processes contribute to a higher demand for advanced foot and ankle devices, including implants, braces, prosthetics, and surgical instruments. 

Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific will create lucrative growth opportunities in the upcoming years. Additionally, the rising preference for minimally invasive surgeries and innovative treatment options among elderly patients further accelerates market expansion. Governments and healthcare providers are increasingly focusing on improving mobility and quality of life for seniors, leading to greater investments in orthopedic care and rehabilitation solutions. 

Consequently, medical device manufacturers are capitalizing on this demographic shift by developing specialized, durable, and patient-friendly foot and ankle devices, ensuring sustained market growth in the coming years. This trend not only enhances revenue prospects for industry players but also fosters advancements in personalized and long-term orthopedic care solutions tailored to the aging population.

Foot and Ankle Device Market Segment Insights

Foot and Ankle Device by Device Type Insights

Based on device type, the Foot and Ankle Device Market has been segmented into orthopedic implants and devices, soft-tissue management devices, prostheses, and bracing and support devices. The orthopedic implants and devices segment held the largest market share in 2024, and the soft-tissue management devices segment is the fastest-growing segment during the forecast period (2025 -2035). Orthopedic Implants and Devices is bifurcated into Fixation Devices, and Joint Implants. Soft-Tissue Management Devices is bifurcated into Artificial Tendons & Ligaments, and Musculoskeletal Reinforcement Devices. 

Prostheses are bifurcated into Solid Ankle Cushion Heel (SACH) Foot, Single-Axial Prostheses, Multiaxial Prostheses, Dynamic Response/Energy-Storing Prostheses, and Microprocessor-Controlled (Mpc) Prostheses. The Orthopedic Implants and Devices segment held the largest share of the Foot and Ankle Device Market in 2024, driven by the increasing incidence of sports injuries, osteoarthritis, and trauma-related fractures. This segment includes Fixation Devices, such as plates, screws, and pins used to stabilize broken bones, and Joint Implants, which are commonly used in ankle replacement surgeries to restore joint function. Technological advancements, minimally invasive surgical techniques, and the growing aging population are further supporting the demand for these devices, making it a key contributor to overall market growth.

Foot and Ankle Device by Application Insights

Based on applications, the Foot and Ankle Device Market has been segmented into trauma, diabetes, neurological disorders, midfoot arthrodesis, deformity correction, and others. The trauma segment held the largest market in 2024, and the diabetes segment is the fastest growing segment during the forecast period. 

The trauma segment accounted for the largest share of the Foot and Ankle Device Market in 2024, primarily due to the rising number of road accidents, falls, and sports-related injuries leading to fractures and dislocations. This segment involves the use of devices such as plates, screws, and fixation systems for the surgical treatment of traumatic injuries. The increasing demand for early mobility, advancements in surgical techniques, and a growing aging population vulnerable to falls are key factors driving the dominance of this segment.

Foot and Ankle Device by End User Insights

Based on end user, the Foot and Ankle Device Market has been segmented into hospitals & clinics, physiotherapy centers, and academic & research organizations. The hospitals & clinics segment held the largest market in 2024, and the physiotherapy Centers segment is the fastest growing segment during the forecast period. 

The hospitals & clinics segment held the largest share of the Foot and Ankle Device Market in 2024, owing to the high volume of surgical procedures, availability of advanced medical infrastructure, and presence of specialized orthopedic departments. These facilities are often the first point of care for trauma and chronic foot and ankle conditions, driving demand for diagnostic, surgical, and post-operative care devices. The segment's growth is further supported by increasing patient admissions, skilled healthcare professionals, and favorable reimbursement policies.

FIGURE 2: FOOT AND ANKLE DEVICE MARKET SHARE BY END USER 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Foot and Ankle Device Regional Insights

Based on the region, the Foot and Ankle Device Market has been segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America accounted for the largest market share in 2024 and is anticipated to reach USD 5.69 billion by 2035. However, Asia-Pacific is projected to grow at the highest CAGR of 9.37% during the forecast period. Major demand factors driving the North America market are a high prevalence of orthopedic disorders, a growing aging population, and increasing cases of sports injuries and diabetes-related foot complications. 

Additionally, the presence of leading medical device manufacturers, advanced healthcare infrastructure, and favorable reimbursement policies contribute to strong market demand. Rising adoption of minimally invasive procedures and continuous innovation in orthopedic technologies further support the region’s market dominance.

FIGURE 3: FOOT AND ANKLE DEVICE MARKET VALUE BY REGION 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Further, the countries considered in the scope of the Application Tracking System Market are the US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC Countries, South Africa, Rest of Middle East & Africa and others.

Global Foot and Ankle Device Key Market Players & Competitive Insights

Many global, regional, and local vendors characterize the Foot and Ankle Device Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.

The major competitors in the market are ORTHOFIX Medical Inc, Arthrex, Inc, INVIBIO Ltd, Stryker, SMITH+NEPHEW, Globus Medical, Inc, CONMED Corporation, Johnson & Johnson Services, Inc, Zimmer Biomet Holdings, Inc, ACUMED LLC are among others. The Foot and Ankle Device Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.

Key Companies in the Foot and Ankle Device Market include

• ORTHOFIX Medical Inc
• Arthrex Inc
• INVIBIO Ltd
• Stryker
• SMITH+NEPHEW
• Globus Medical Inc
• CONMED Corporation
• Johnson & Johnson Services, Inc
• Zimmer Biomet Holdings, Inc
• ACUMED LLC

Foot Ankle Device Industry Developments

• Q2 2024: Enovis Announces FDA 510(k) Clearance for STAR Patient Specific Instrumentation (PSI) for Total Ankle Replacement Enovis received FDA 510(k) clearance for its STAR Patient Specific Instrumentation (PSI), designed to improve accuracy and efficiency in total ankle replacement procedures.
• Q2 2024: Paragon 28 Announces Launch of Phantom® High Arch System for Foot and Ankle Reconstruction Paragon 28 launched the Phantom® High Arch System, a new device intended for complex foot and ankle reconstruction, expanding its portfolio of surgical solutions.
• Q1 2024: Stryker launches Prophecy® Infinity Resect-Through Guides for Total Ankle Arthroplasty Stryker introduced the Prophecy® Infinity Resect-Through Guides, a new technology to enhance precision in total ankle arthroplasty procedures.
• Q2 2024: Ossio Receives FDA Clearance for OSSIOfiber® Hammertoe Fixation System Ossio received FDA clearance for its OSSIOfiber® Hammertoe Fixation System, a bio-integrative implant for hammertoe correction in foot and ankle surgeries.
• Q1 2024: Paragon 28 Announces FDA Clearance and Launch of SMART 28™ Screw System Paragon 28 received FDA clearance and launched the SMART 28™ Screw System, designed for use in foot and ankle fixation procedures.
• Q2 2024: Enovis Completes Acquisition of Novastep to Expand Foot and Ankle Portfolio Enovis completed the acquisition of Novastep, a company specializing in foot and ankle solutions, to broaden its product offerings in the sector.
• Q1 2024: Stryker Announces Opening of New Global Technology Development Center in India Stryker opened a new Global Technology Development Center in India, which will focus on research and development for orthopedic devices, including foot and ankle products.
• Q2 2024: Paragon 28 Announces Launch of Gorilla® Medial Column Plating System Paragon 28 launched the Gorilla® Medial Column Plating System, designed to address complex foot and ankle deformities.
• Q1 2024: Enovis Announces Launch of DynaNail Helix™ for Charcot Foot and Ankle Reconstruction Enovis launched the DynaNail Helix™, a new device for Charcot foot and ankle reconstruction, expanding its advanced fixation solutions.
• Q2 2024: Ossio Announces $38.5 Million Series C Financing to Accelerate Commercialization of Bio-Integrative Implants Ossio raised $38.5 million in Series C funding to support the commercialization of its bio-integrative implants for foot and ankle procedures.
• Q1 2024: Paragon 28 Appoints New Chief Commercial Officer Paragon 28 appointed a new Chief Commercial Officer to drive commercial strategy and growth in the foot and ankle device market.
• Q2 2024: Enovis Announces Partnership with Movendo Technology to Advance Robotic Rehabilitation for Foot and Ankle Patients Enovis entered a partnership with Movendo Technology to integrate robotic rehabilitation solutions into foot and ankle patient care.

Foot and Ankle Device Market Segmentation

Foot and Ankle Device by Device Type Outlook

• Orthopedic Implants and Devices
  • Fixation Devices
    • Internal Fixation Devices
      • Screws
      • Plates
      • Wires & Pins
      • Fusion Nails
      • Staple 
    • External Fixation Devices
      • Unilateral Fixators 
      • Ring Ankle Fixators
      • Hybrid Fixators
  • Joint Implants
    • Ankle Implants (Ankle Replacement Devices)
    • Subtalar Joint Implants/Subtalar Joint Reconstruction Devices 
    • Phalangeal Implants
• Soft-Tissue Management Devices
  • Artificial Tendons & Ligaments
  • Musculoskeletal Reinforcement Devices
• Prostheses
  • Solid Ankle Cushion Heel (SACH) Foot       
  • Single-Axial Prostheses       
  • Multiaxial Prostheses       
  • Dynamic Response/Energy-Storing Prostheses        
  • Microprocessor-Controlled (Mpc) Prostheses     
• Bracing and Support Devices

Foot and Ankle Device by Application Outlook

• Trauma
• Diabetes
• Neurological Disorders   
• Midfoot Arthrodesis   
• Deformity Correction   
• Others

Foot and Ankle Device by End User Outlook

• Hospitals & Clinics
• Physiotherapy Centers
• Academic & Research Organizations 

Foot and Ankle Device Regional Outlook

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Mexico
  • Argentina
  • Rest of South America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Report Attribute/Metric	Details
Market Size 2024	USD 5.88 Billion
Market Size 2025	USD 6.25 Billion
Market Size 2035	USD 12.68 Billion
Compound Annual Growth Rate (CAGR)	7.32% (2025-2035)
Base Year	2024
Forecast Period	2025-2035
Historical Data	2019-2023
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Device Type, By Application, By End User
Geographies Covered	North America, Europe, Asia Pacific, South America, Middle East & Africa
Countries Covered	The US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC Countries, South Africa, Rest of Middle East & Africa
Key Companies Profiled	ORTHOFIX Medical Inc, Arthrex, Inc, INVIBIO Ltd, Stryker, SMITH+NEPHEW, Globus Medical, Inc, CONMED Corporation, Johnson & Johnson Services, Inc, Zimmer Biomet Holdings, Inc, ACUMED LLC
Key Market Opportunities	·         Growing geriatric population ·         Technological advancements in device design
Key Market Dynamics	·         Increasing incidence of sports-related injuries ·         Rising awareness and patient education